The Alzheimer’s Association has pushed relentlessly to get broad access to Aduhelm, despite safety risks and uncertain evidence that it helps patients.
Tag: Drugs (Pharmaceuticals)
-
How to Prepare for BA.2, the Omicron Subvariant
Taking these seven steps now can lower your risk and minimize the disruption to your family’s life.
-
House Passes Bill to Limit Cost of Insulin to $35 a Month
The bill stands to benefit millions of Americans with diabetes, but to become law, it will need to attract at least 10 Republican votes in the Senate
-
New ALS Treatment, AMX0035, Lacks Evidence of Benefit, FDA Panel Finds
With a 6-4 vote, the group of independent advisers to the agency narrowly concluded that results from another clinical trial are needed to assess whether the therapy, called AMX0035, can help patients.
-
Ivermectin Does Not Reduce Risk of Covid Hospitalization, Large Study Finds
“At some point it will become a waste of resources to continue studying an unpromising approach,” one expert said.